CABA · Cabaletta Bio, Inc. · Exempt Offerings
$0.94
-0.07 (-7.32%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Nov 5, 2026
The latest filing states the doubt was alleviated.
“As disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, we had previously identified conditions that raised substantial doubt about our ability to continue as a going concern. During the quarter ended September 30, 2026, we raised additional funds through the exercise of common stock warrants for proceeds of $115.0 million and sold 1.9 million shares pursuant to the 2025 ATM Program for net proceeds of $6.0 million. As a result of these cash raises, the conditions that previously raised substantial doubt are no longer present.”View the 10-Q filed Nov 5, 2026
Market Cap
$201.94M
Shares
215.72M
Volume · Nov 20
3.74M
Avg daily vol (3M)
5.14M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1759138
CUSIP
12674W109
13F (30d)
169 filings
157 filers
Visit website
Investor relations